STRO·869367201·US·equity·Healthcare - Biotechnology-13D/G
STRO (SUTRO BIOPHARMA INC) is held by 40 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($17.8M), Point72 Asset Management, L.P. ($17.2M), BALYASNY ASSET MANAGEMENT L.P. ($11.6M). Net institutional sentiment: Bullish.
See how STRO's score breaks down across 4 SEC sources
Showing 1-20 of 44
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer